Skip to Content

Fidelity® Select Biotechnology FBIOX

Quantitative rating as of
NAV / 1-Day Return
16.30  /  0.74 %
Total Assets
5.4 Bil
Adj. Expense Ratio
0.690%
Expense Ratio
0.690%
Distribution Fee Level
Low
Share Class Type
No Load
Category
Health
Investment Style
Mid Growth
Min. Initial Investment
0
Status
Open
TTM Yield
0.00
Turnover
46%

Morningstar’s Analysis FBIOX

Will FBIOX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

An incline in People Pillar rating is the primary driver of Fidelity® Select Biotechnology's upgrade to a Morningstar Quantitative Rating of Bronze from Neutral. The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Unlock our full analysis with Morningstar Investor